Genelle Slagle
Family Medicine · Kansas City, MONPI 1861560948
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 148 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,718 and has fallen 98.9% since, to $18 in 2025.
Across 148 payments — averaging $14.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$389
- Amarin Pharma, Inc.$232
- Lilly USA, LLC$221
- Novo Nordisk$201
- Amgen$195
- Biohaven Pharmaceuticals, Inc.$105
- plus $861 from 20 others
What the payments were for
- Food & beverage$2,204100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 28 | $389 |
| Amarin Pharma, Inc. | 15 | $232 |
| Lilly USA, LLC | 15 | $221 |
| Novo Nordisk | 13 | $201 |
| Amgen | 14 | $195 |
| Biohaven Pharmaceuticals, Inc. | 6 | $105 |
| AstraZeneca | 8 | $97 |
| Boehringer Ingelheim | 5 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Merck | 6 | $80 |
| Esperion Therapeutics, Inc. | 5 | $69 |
| Collegium Pharmaceutical, Inc. | 4 | $58 |
| Abbott | 2 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $41 |
| Mylan Specialty L.p. | 3 | $39 |
| Endo Pharmaceuticals Inc. | 3 | $38 |
| Boston Scientific | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Eisai Inc. | 2 | $28 |
| Optos, Inc. | 1 | $18 |
| GSK | 1 | $18 |
| Adlon Therapeutics L.p. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $14 |
| Novartis | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$2,204 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Kansas City
- Blair ThedingerKansas City$71K
- Jon MattsonKansas City$53K
- Meredith LevineKansas City$26K
- Kelly SandriKansas City$17K
- Michael SimanovskyKansas City$16K
- Teresa MarshallKansas City$16K
- Nora GomezKansas City$15K
- Julie AlvarezKansas City$15K
- Neal MooreKansas City$14K
- Stephen AdamsSpringfield$636K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.